These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1563833)

  • 21. Epidermal growth factor (EGF), transforming growth factor-alpha (TGF-alpha), and basic fibroblast growth factor (bFGF) differentially influence neural precursor cells of mouse embryonic mesencephalon.
    Santa-Olalla J; Covarrubias L
    J Neurosci Res; 1995 Oct; 42(2):172-83. PubMed ID: 8568917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor beta 1 suppresses transformation in hepatocytes by regulating alpha 1 beta 1 integrin expression.
    Serra R; Carbonetto S; Lord M; Isom HC
    Cell Growth Differ; 1994 May; 5(5):509-17. PubMed ID: 8049157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the transforming growth factor beta-like activity of synthetic polypeptides comprising the amino-terminal sequence of human parathyroid hormone-related peptide.
    Kikuchi H; Shigeno C; Lee K; Ohta S; Shiomi K; Ikeda T; Sone T; Dokoh S; Konishi J
    Endocrinology; 1991 Mar; 128(3):1229-37. PubMed ID: 1999144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroblasts transformed by chemical carcinogens are sensitive to intercellular induction of apoptosis: implications for the control of oncogenesis.
    Panse J; Hipp ML; Bauer G
    Carcinogenesis; 1997 Feb; 18(2):259-64. PubMed ID: 9054616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2).
    Strutz F; Zeisberg M; Renziehausen A; Raschke B; Becker V; van Kooten C; Müller G
    Kidney Int; 2001 Feb; 59(2):579-92. PubMed ID: 11168939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of transformation frequency by exogenous and endogenous growth factors in rat tracheal epithelial cells.
    Gray TE; Zhu SJ; Nettesheim P
    Carcinogenesis; 1994 Mar; 15(3):549-55. PubMed ID: 8118942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cell cycle and mutational analysis of anchorage-independent growth: cell adhesion and TGF-beta 1 control G1/S transit specifically.
    Han EK; Guadagno TM; Dalton SL; Assoian RK
    J Cell Biol; 1993 Jul; 122(2):461-71. PubMed ID: 8320267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of transforming growth factor beta on the anchorage-independent growth of murine epithelial JB6 cells.
    Wilder PJ; Rizzino A
    Cancer Res; 1991 Nov; 51(21):5898-902. PubMed ID: 1933858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formation of cartilage-like spheroids by micromass cultures of murine C3H10T1/2 cells upon treatment with transforming growth factor-beta 1.
    Denker AE; Nicoll SB; Tuan RS
    Differentiation; 1995 Jul; 59(1):25-34. PubMed ID: 7589892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
    Coppa A; Mincione G; Lazzereschi D; Ranieri A; Turco A; Lucignano B; Scarpa S; Ragano-Caracciolo M; Colletta G
    J Cell Physiol; 1997 Aug; 172(2):200-8. PubMed ID: 9258341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transforming growth factor beta 1 partially suppresses the transformed phenotype of ras-transformed hepatocytes.
    Serra R; Verderame MF; Isom HC
    Cell Growth Differ; 1992 Oct; 3(10):693-704. PubMed ID: 1332741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orthovanadate both mimics and antagonizes the transforming growth factor beta action on normal rat kidney cells.
    Rijksen G; Völler MC; Van Zoelen EJ
    J Cell Physiol; 1993 Feb; 154(2):393-401. PubMed ID: 8425920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor beta 1 induces squamous carcinoma cell variants with increased metastatic abilities and a disorganized cytoskeleton.
    Frontelo P; González-Garrigues M; Vilaró S; Gamallo C; Fabra A; Quintanilla M
    Exp Cell Res; 1998 Nov; 244(2):420-32. PubMed ID: 9806792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TGF-beta inhibits Akt-induced transformation in intestinal epithelial cells.
    Cao Y; Deng C; Townsend CM; Ko TC
    Surgery; 2006 Aug; 140(2):322-9. PubMed ID: 16904986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
    Fernandez-Pol JA; Klos DJ; Grant GA
    Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of proliferation and migration in retinoic acid treated C3H10T1/2 cells by TGF-beta isoforms.
    Makhijani NS; Bischoff DS; Yamaguchi DT
    J Cell Physiol; 2005 Jan; 202(1):304-13. PubMed ID: 15389595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intestinal transformation results in transforming growth factor-beta-dependent alteration in tumor cell-cell matrix interactions.
    Berger DH; O'Mahony CA; Sheng H; Shao J; Albo D; DuBois RN; Beauchamp RD
    Surgery; 2003 May; 133(5):568-79. PubMed ID: 12773985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catechol interferes with TGF-beta-induced elimination of transformed cells by normal cells: implications for the survival of transformed cells during carcinogenesis.
    Schaefer D; Jürgensmeier JM; Bauer G
    Int J Cancer; 1995 Feb; 60(4):520-6. PubMed ID: 7829267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered responsiveness of rat liver epithelial cells to transforming growth factor beta 1 following their transformation with v-raf.
    Huggett AC; Hampton LL; Ford CP; Wirth PJ; Thorgeirsson SS
    Cancer Res; 1990 Dec; 50(23):7468-75. PubMed ID: 2174726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transforming growth factor type-β inhibits Mas receptor expression in fibroblasts but not in myoblasts or differentiated myotubes; Relevance to fibrosis associated to muscular dystrophies.
    Cofre C; Acuña MJ; Contreras O; Morales MG; Riquelme C; Cabello-Verrugio C; Brandan E
    Biofactors; 2015; 41(2):111-20. PubMed ID: 25809912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.